Adapt and overcome in response to the Covid-19 crisis
23 April 2020
FOR ANY FURTHER INFORMATION,
PLEASE CONTACT:
communication@medincell.com
Our news
Bringing you the latest!
All news
MedinCell launches Regulatory Development of mdc-WWM Program
22 April 2020
Invitation to a webcast: adapting and acting in response to the Covid-19 crisis
20 April 2020
MedinCell has launched a COVID-19 research initiative based on its experience to formulate long-acting injectable Ivermectin
6 April 2020
MedinCell receives $ 6.4 million grant from Unitaid to fight Malaria
25 March 2020
MedinCell provides a portfolio update for J.P. Morgan Healthcare Conference 2020
13 January 2020
Publication of the activity report and financial information for the first half-year (April – Sept. 2019)
3 December 2019
MedinCell receives $19 million grant for its mdc-WWM program
28 November 2019
Press
Communication leader
MedinCell
David Heuzé
david.heuze@medincell.com
+33 (0)6 83 25 21 86
Media
NewCap
Nicolas Merigeau
medincell@newcap.eu
+33 (0)1 44 71 94 94
Investors
Investor Relations
NewCap
Louis-Victor Delouvrier /
Alexia Faure
medincell@newcap.eu
+33 (0)1 44 71 94 94